3578 results for «2389»
3578 results
TAVI outcomes - Part 2
21 Nov 2023 – From PCR London Valves 2023
Explore the latest insights in TAVI outcomes with this session: delve into the pursuit of transatlantic harmonization in echocardiography core laboratory analysis and adjudication according to VARC3 guidelines, investigate the nuances of TAV deployment within an elliptical aortic root, uncover the clinical impact of multiple resheathing...
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
TAVI - Vascular complications
21 Nov 2023 – From PCR London Valves 2023
Learn valuable insights into vascular complications management and prevention during TAVI with this session: navigate the challenges of a post-TAVI common femoral artery occlusion in a patient with a previously implanted bioabsorbable closure device, witness the difficulties of common iliac artery stent dislodgment, explore the rare...
Don't forget the nurses and allied professionals when introducing new technology!
19 Nov 2023 – From PCR London Valves 2023
Learn all you need to know about adopting new technology, bearing in mind that both trainer and trainee share learning responsibilities and that focus should be on collaboration with industry and variety of teaching methods.
TAVI - complications
21 Nov 2023 – From PCR London Valves 2023
Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
Coronary imaging in the structural cathlab
21 Nov 2023 – From PCR London Valves 2023
If you still have any doubts, take a look at the presentations in this PCR LV 2023 session to be convinced of the importance of imaging, particularly IVUS, pre-, during and post-TAVI! It helps to prevent coronary artery occlusions, manage post-TAVR complications and guide rotablation, to name...
Interventions for multiple valve disease
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover innovative strategies for managing multiple valve diseases: witness the strategic staging of treatments using two distinct devices for mitigating mitral and tricuspid regurgitation, navigate the challenges encountered in a patient presenting with severe mitral and tricuspid regurgitation and unable for edge-to-edge procedures,...
TAVI durability and potential future solutions - LIVE case
19 Nov 2023 – From PCR London Valves 2023
In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.
- Live case: An 83-year-old woman with type 2 diabetes, COPD...
Alternative structural interventions
21 Nov 2023 – From PCR London Valves 2023
Join us in this session as we delve into unconventional structural interventions through two distinct studies: one focusing on evaluating the quality of trials investigating percutaneous PFO closure as a potential treatment for migraines, the other exploring the novel landscape of percutaneous procedures extending beyond the...
Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?
19 Nov 2023 – From PCR London Valves 2023
Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...
Aortic regurgitation - Part 2
21 Nov 2023 – From PCR London Valves 2023
Dive into this session on aortic regurgitation to uncover the promising short-term outcomes of managing aortic regurgitation in patients with LVADs using a specialized TAVI device, to gain insights from an intermodal assessment approach utilizing both cardiac CT and MRI to evaluate the severity of aortic...
Advanced imaging for structural interventions
21 Nov 2023 – From PCR London Valves 2023
Learn more about advanced imaging in structural interventions with this session: explore the utility of image fusion in guiding repeat TAVR for THV dysfunction, witness the precision of solo four-dimensional intracardiac echocardiography guiding TEER for tricuspid regurgitation, delve into the peri-procedural use of IVUS during bicaval...
Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 2): what do I need to know to manage complex clinical scenarios?
19 Nov 2023 – From PCR London Valves 2023
Navigate complex mitral valve interventions in this session: explore techniques for performing transseptal punctures in challenging septal anatomy, uncover how to achieve optimal outcomes in complex mitral anatomy, and learn how to effectively manage complications that may arise during transcatheter mitral edge-to-edge repair.
Valve in valve - Pulmonary - Part 3
21 Nov 2023 – From PCR London Valves 2023
Explore a selection of pulmonary valve-in-valve cases, showcasing transcatheter management of recurrent severe pulmonary regurgitation, a rare intervention for calcified bioprosthetic pulmonary valve leaflets, and strategic approaches to early valve degeneration.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
